Skip to main navigation Skip to search Skip to main content

Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors

Research output: Contribution to journal › Article › peer-review

Abstract

A series of HIV-1 protease inhibitors based on the lead compound Pc (IC50 = 165 nmol/l) with structural modifications at P1/P1' substituents or with a lengthening at its core unit were synthesized from amino acid starting materials. All analogues were less active than Pc against the protease.

Original languageEnglish (US)
Pages (from-to)564-568
Number of pages5
JournalArzneimittel-Forschung/Drug Research
Volume50
Issue number6
DOIs
StatePublished - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HIV-1 protease inhibitors
  • Peptidomimetics

Fingerprint

Dive into the research topics of 'Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors'. Together they form a unique fingerprint.

Cite this